Jeff-CHAT Offers students an Interprofessional Forum to Discuss Experiences

Feelings of frustration, loss, and exhaustion are common among healthcare workers. Students placed among new experiences and in a dependent learning role are not shielded from these emotions but often experience them differently from other members of the healthcare team. In addition to the systematic and individual support available through TJUH, for the past year and a half Jeff‐ CHAT (Compassion, Humanism, Altruism, Trust) has provided a forum for students to discuss and reflect on difficult emotions and situations

Survivorship Care For Women Living With Ovarian Cancer: Protocol For a Randomized Controlled Trial

BACKGROUND: Ovarian cancer ranks 12th in cancer incidence among women in the United States and 5th among causes of cancer-related death. The typical treatment of ovarian cancer focuses on disease management, with little attention given to the survivorship needs of the patient. Qualitative work alludes to a gap in survivorship care; yet, evidence is lacking to support the delivery of survivorship care for individuals living with ovarian cancer. We developed the POSTCare survivorship platform with input from survivors of ovarian cancer and care partners as a means of delivering patient-centered survivorship care. This process is framed by the chronic care model and relevant behavioral theory. OBJECTIVE: The overall goal of this study is to test processes of care that support quality of life (QOL) in survivorship. The specific aims are threefold: first, to test the efficacy of the POSTCare platform in supporting QOL, reducing depressive symptom burden, and reducing recurrence worry. In our second aim, we will examine factors that mediate the effect of the intervention. Our final aim focuses on understanding aspects of care platform design and delivery that may affect the potential for dissemination. METHODS: We will enroll 120 survivors of ovarian cancer in a randomized controlled trial and collect data at 12 and 24 weeks. Each participant will be randomized to either the POSTCare platform or the standard of care process for survivorship. Our population will be derived from 3 clinics in Texas; each participant will have received some combination of treatment modalities; continued maintenance therapy is not exclusionary. RESULTS: We will examine the impact of the POSTCare-O platform on QOL at 12 weeks after intervention as the primary end point. We will look at secondary outcomes, including depressive symptom burden, recurrence anxiety, and physical symptom burden. We will identify mediators important to the impact of the intervention to inform revisions of the intervention for subsequent studies. Data collection was initiated in November 2023 and will continue for approximately 2 years. We expect results from this study to be published in early 2026. CONCLUSIONS: This study will contribute to the body of survivorship science by testing a flexible platform for survivorship care delivery adapted for the specific survivorship needs of patients with ovarian cancer. The completion of this project will contribute to the growing body of science to guide survivorship care for persons living with cancer. TRIAL REGISTRATION: ClinicalTrials.gov NCT05752448; https://clinicaltrials.gov/study/NCT05752448. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/48069

A Novel Program for Students to Share Experiences and Emotions During Clinical Years in a Student-Run, Multidisciplinary Format

Schwartz Center Rounds is a multi-disciplinary forum for discussing emotional issues that arise in caring for patients. The program aims to improve patient care by promoting better communication and compassion among healthcare providers. Modeled after Schwartz Center Rounds, Jeff-CHAT was created atThomasJeffersonUniversityin 2011 as a novel opportunity for students from various health professions to share their experiences during their clinical education. Therefore, Jeff-CHAT strives to promote reflection and foster compassion among future healthcare providers. The monthly, lunchtime rounds are organized and facilitated by students, with the support of a multi-disciplinary group of faculty. The rounds begin with student panelists from three different disciplines who share a personal vignette related to a chosen theme (e.g., “A difficult patient…”). Open discussion, which is facilitated by a student, constitutes the remaining time. A debriefing with the panelists and leaders follows the rounds. Eight Jeff-CHAT rounds have taken place with attendance ranging from thirty to seventy students. Based upon review of evaluations, Jeff-CHAT has been well received by students from all disciplines. Overall, students have reported that Jeff-CHAT has increased their understanding of common experiences and emotions among students from other disciplines. Additionally, students have expressed that Jeff-CHAT is a good environment for expressing feelings, and that more students should participate. Almost all students have rated each rounds “excellent” or “exceptional”. The multi-disciplinary aspect of the rounds has emerged as the strength of the program. Open sharing and discussion of challenging topics allows students to discover the common humanism and ideals amongst the disciplines, while learning about the training of each discipline. The non-classroom, student-run format creates a safe, open environment for students to learn about each other in a novel manner. Similar opportunities should be made available to students in all settings, particularly at multi-disciplinary training institutions. Learning Objectives: 1. Participants will be able to identify how programs like Jeff-CHAT improve inter-professional education. 2. Participants will be able to incorporate student-run programs into their inter-professional activities

The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian epithelial cancer, specifically as it relates to the management of peritoneal surface malignancy. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments. When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments